What if biotech teams could automate the most tedious parts of bringing a drug to market?
In this new episode of Data in Biotech, host Ross Katz sits down with Alex Telford and Maged Ahmed, co-founders of Convoke, to explore how they’re building an AI-native operating system for biopharma.
From clinical trial design to regulatory writing, Convoke is redefining how biotech teams structure knowledge, automate insights, and accelerate decision-making.
Tune in to learn:
>> Why AI-native workflows are the future of biotech ops
>> How Convoke structures data and documents at scale
>> What it takes to build trust in LLM-driven systems
>> The surprising upside beyond time savings
This one is a must-listen for biotech execs, data scientists, and AI engineers alike.